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Determination of penicillamine, tiopronin and glutathione 
in pharmaceutical formulations by kinetic spectrophotometry
A novel and simple method for the determination of peni-
cillamine (PEN), tiopronin (mercaptopropionyl glycine, 
MPG) and glutathione (GSH) in pharmaceutical formula-
tions by kinetic spectrophotometry has been developed 
and validated. It is based on the redox reaction where the 
thiol compound (RSH) reduces CuII-neocuproine complex 
to CuI-neocuproine complex. The non-steady state signal of 
the formed CuI- neocuproine complex is measured at 458 
nm. The initial rate and fixed time (at 1 min) methods were 
validated. The calibration graph was linear in the concen-
tration range from 8.0 × 10‒7 to 8.0 × 10‒5 mol L–1 for the ini-
tial rate method and from 6.0 × 10‒7 to 6.0 × 10‒5 mol L–1 for 
the fixed time method, with the detection limits of 2.4 × 10‒7 
and 1.4 × 10‒7 mol L–1, resp. Levels of PEN, MPG and GSH in 
pharmaceutical formulations were successfully assayed by 
both methods. The advantages of the presented methods 
include sensitivity, short analysis time, ease of application 
and low cost.
Keywords: penicillamine, tiopronin, glutathione, kinetic 
spectrophotometry, pharmaceutical formulations
Penicillamine (PEN) is a synthetic amino acid that contains an additional SH group and 
is capable of forming non-toxic, water-soluble chelates with heavy metals, which are then 
excreted in the urine. PEN was the first chelator used for Wilson’s disease and it can be also 
used for lead, mercury and arsenic poisoning (1, 2). Tiopronin (mercaptopropionyl glycine, 
MPG) is a synthetic aminothiol with reducing and complexation properties used primarily 
for the treatment of cystinuria, as it increases cystine solubility (3, 4). Glutathione (γ-L-
glutamyl-L-cysteinyl-glycine, GSH) is the most important hydrophilic intracellular antioxi-
dant that protects cells against reactive oxygen (ROS) and nitrogen (RNS) species. Supple-
mentation with GSH showed antiaging and hepatoprotective effects in humans (5–7).
Official methods (from the British Pharmacopoeia) for determination of these thiol 
compounds (RSH) are acid-base titration in a non-aqueous medium for PEN and redox 
titration for MPG and GSH (8). Other reported methods for determination of these RSH 
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(9–15), fluorimetry (16–19) chemiluminescence (20–22), electroanalytical techniques  (23–27), 
chromatography (28–30) and flow techniques (31–35).
Nevertheless, these methods are insufficiently sensitive and selective, or overly expen-
sive due to expensive instrumentation. In fact, the spectrophotometric technique is the one 
routinely used in the pharmaceutical analysis for quality control, due to its simplicity, 
availability, and low price. Kinetic methods allow sensitive and selective determination of 
many analytes within a few minutes, usually with no sample pretreatment. The applica-
tion of kinetic spectrophotometric methods offers an advantage over classical spectro-
photometry, such as improved selectivity, and shorter time per analysis.
The literature of kinetic spectrophotometric methods for the determination of the 
PEN, MPG and GSH in pharmaceutical formulations is relatively limited. At the best of our 
knowledge, there are only four published kinetic spectrophotometric methods for deter-
mination of PEN (36–39), and none for MPG or GSH; besides, the methods for determina-
tion of PEN (40) and MPG (41) were developed by our team.




All reagents and chemicals used in the present study were of analytical grade and 
were used without further purification. Milli-Q (Millipore) double deionized water was 
used as an appropriate diluent.
Stock solutions of thiol compounds RSH (c(RSH) = 1.0 × 10–2 mol L−1) were prepared by 
dissolving the appropriate amount of thiol compound: 0.1492 g of PEN (Fluka Chemika, 
Switzerland), 0.1632 g of MPG (Sigma-Aldrich, USA), 0.3073 g of GSH (Sigma-Aldrich) in 
Britton-Robinson buffer solution (pH = 2) and diluted to a nominal volume of 100.0 mL in 
the volumetric flask. The stock solutions were stored at 4 °C in a dark bottle and were 
stable for at least 30 days. Working standards of lower concentrations were prepared daily 
by diluting the stock solutions with Britton-Robinson buffer solution (pH = 3).
The oxidizing solution of copper(II)-neocuproine reagent was prepared by dissolving 
25.0 mg of copper(II) sulfate pentahydrate (Kemika, Croatia) and 50.0 mg of neocuproine 
hydrate (Nc, Sigma-Aldrich) (1.0 mmol L–1 Cu(II) + 2.4 mmol L–1 Nc) in 100.0 mL Britton- 
-Robinson buffer solution (pH = 3). Neocuproine (2,9-dimethyl-1,10-phenantroline) is slightly 
soluble in water, thus its solubility is improved when complex copper(II)-neocuproine, 
Cu(Nc)22+, is formed. Copper(II)-neocuproine reagent was stable for at least 30 days when 
stored at 4 °C.
Three commercially available pharmaceutical preparations were analyzed in this 
work: Metalcaptase tablets, 300 mg of PEN (HEYL Chemisch-Pharmazeutische Fabrik 
GmbH & Co. KG, Germany), Captimer tablets, 100 mg of MPG (MIT Gesundheit GmbH, 
Germany) and L-glutathione capsules, 50 mg of GSH (Solaray, USA). Ten PEN-containing 
tablets, or ten MPG-containing tablets, were weighed and pulverized. A powder quantity 
equivalent to 300 mg of PEN, or 100 mg of MPG, was dissolved in 300 mL of water, filtered 
through filter paper, and the filtrate collected in a 500-mL volumetric flask and diluted 
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with water. The content of ten GSH-containing capsules was weighed and mixed. A 
 powder quantity equivalent to 50 mg of GSH was dissolved in 500 mL of water. These solu-
tions are not stable and should be analysed within 24 hours.
Iodine, sodium thiosulfate and perchlorate acid solutions were prepared and standard-
ized according to the literature (8).
Apparatus and procedure
Spectrophotometric kinetic measurements were carried out by the instrumentation 
consisting of the peristaltic pump (IPC Ismatec, Switzerland) with the appropriate PTFE 
tubing of 0.8 mm i.d. that allows a continuous flow of reagent solution, magnetic stirrer 
that provides equal mixing of the total volume of reagent solution and a double beam 
Shimadzu UV-1601 UV/Vis spectrophotometer (Shimadzu, Japan) as a detector, equipped 
with a 160-µL inner volume quartz flow cell. Six mL of Britton Robinson buffer (pH = 3.0), 
2.5 mL of copper(II) neocuproine complex and 15.5 mL of deionized water were added in 
a thermostated double-wall vessel placed on the magnetic stirrer. Constant temperature 
was maintained by a thermostated water pump (Julabo, Germany) with an external flow. 
The reaction was started by adding 1.0 mL of analyte 1 minute after the beginning of the 
experiment yielding the final volume of the reaction mixture of 25.0 mL. The absorbance 
of the formed complex Cu(Nc)2+ was continuously measured at a wavelength of 458 nm 
using a UV-Vis spectrophotometer with a flow cell during the reaction. The kinetic mani-
fold and other instrumentation have been previously described in more detail (42).
The recorded kinetic data, with the frequency of 1 s–1, were transferred to a software 
package, GraphPad Prism Ver. 4.03 for Windows (GraphPad Software, San Diego, CA, 
USA) for curve fitting, regression analysis and statistics. Details of data processing have 
been previously described (42).
Analytical performances
The precision and accuracy of the method were estimated from recovery studies. Pre-
cision was expressed as RSD (%) from three replicates. For recovery (%) calculation known 
amounts of RSH standards were added to pharmaceutical formulation pre-analysed by the 
proposed methods. Limit of detection, LOD, was calculated as three standard deviations 
of a blank divided by the slope of the calibration curve. The influence of possible interfer-
ing substances was tested by measuring RSH concentration in synthetic solutions contain-
ing RSH (c = 4.0 × 10–5 mol L–1) and different concentrations of foreign substances or ions. 
The tolerable tolerance limit was defined as the concentration of interfering substances that 
would cause an error of less than ± 5 %.
RESULTS AND DISCUSSION
The proposed methods for the determination of RSH are based on the redox reaction (Eq. 
1) in which RSH reduces copper(II)-neocuproine complex (Cu(Nc)22+) to a yellow-orange 
copper(I)-neocuproine complex (Cu(Nc)2+), having an absorption maximum at λ = 458 nm (15):
 2 RSH + 2 Cu(Nc)22+   RSSR + 2 Cu(Nc)2+ + 2 H+ (1)
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Absorption spectra of the analyte (RSH), reagent (copper(II)-neocuproine) and reac-
tion products (coloured copper(I)-neocuproine) are shown in Supplemental Fig. S1.
As we have previously reported, this redox reaction is very fast and the product Cu(Nc)2+ 
is relatively unstable, which underlines the need for kinetic measurement under dynamic 
conditions (changes in the concentrations of reactants and products per time) (43).
Methods optimization
The optimal pH was tested over the range from 2.0 to 6.0 using the Britton-Robinson 
buffer solution. Although all RSHs are more stable at lower pH, there was a significant 
difference between kinetic signals for the three analytes at the observed pH values. The 
PEN and GSH signals are stable in the pH range 2–3, but at pH 3 the reaction rate is signi-
ficantly higher. At higher pH values, the signals are unstable. On the other hand, the 
 signals for MPG were unstable at pH = 2 and pH = 6, whereas at pH = 3 the signal was 
stable (Fig. 1). Therefore, the reaction medium of Britton-Robinson buffer pH 3.0 was 
 selected for further measurements. Our results regarding the optimum pH for this  reaction 
are in accordance with our previous study (43), but do somehow differ from the article that 
introduced the copper(II)-neocuproine as a colour reagent (15).
Fig. 1. Absorbance (l = 458 nm) vs. time dependence at different pH values: pH = 2.0, 3.0, 6.0. Experi-
mental conditions: c(RSH) = 4.0 × 10−5 mol L−1; c(Cu2+) = 8.0 × 10−5 mol L−1; c(Nc) = 1.9 × 10−4 mol L−1; 
temperature 25 °C. The analyte was added 1 minute after the beginning of the experiment. Panels 
a), b) and c) show the kinetic signal for PEN, MPG and GSH, resp.
a)                                                                               b)
c)
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The optimum molar ratio of neocuproine and copper(II) in the reaction mixture was 
tested over the range from 1.0 to 3.5, by maintaining the concentration of copper(II) con-
stant, (c(Cu2+) = 8.0 × 10–5 mol L–1). Both the reaction rate and absorbance increased with an 
increase of the molar ratio, by reaching a constant value at molar ratio 2.4. Therefore, the 
optimum molar ratio of neocuproine and copper(II) is 2.4 for all analyzed thiol compounds.
The effect of temperature on the reaction kinetics was tested over the range from 5 to 
60 °C, by changing the temperature in the reaction vessel. The reaction rate and signal 
stability remained unaffected over a wide range of temperatures. The laboratory tempera-
ture of 25 °C was selected as optimum, so the experiment can be carried out without 
thermostating the kinetic system during the measurement.
Kinetics of the reactions
The absorbance-time curves for the reaction at varying RSH concentrations (6.0 × 10–7 
to 8.0 × 10–5 mol L–1) with fixed analytical concentrations of Cu2+ (1.0 × 10–4 mol L–1) and 
neocuproine (2.4 × 10–4 mol L–1) were generated (Fig. 2), following the optimum conditions 
described above.
Fig. 2. Absorbance (l = 458 nm) vs. time dependence for the considered RSH at optimized experimental 
conditions: c(RSH) = 6.0 × 10−7, 8.0 × 10−7, 1.0 × 10−6, 2.0 × 10−6, 4.0 × 10−6, 6.0 × 10−6, 8.0 × 10−6, 1.0 × 10−5, 
2.0 × 10−5, 4.0 × 10−5, 6.0 × 10−5, 8.0 × 10−5 mol L−1; c(Cu2+) = 1.0 × 10−4 mol L−1; c(Nc) = 2.4 × 10−4 mol L−1; 
 pH = 3.0; temperature 25 °C. Analyte was added 1 minute after the beginning of the experiment. 
Panels a), b) and c) show the kinetic signal for PEN, MPG and GSH, resp.
a)                                                                              b)
c)
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Quantitation methods
Initial rate method. – The initial reaction rates (K) were calculated from the slopes of 
absorbance-time curves. Regression analysis using a method of least squares was per-
formed to obtain slope, intercept and coefficient of determination (R2) values, by fitting the 
data in the following equation:





 = log k’ + n log c (2)
where K is the reaction rate, A is absorbance, t is the reaction time, k´ is the pseudo-first 
order rate constant, c is the molar concentration of RSH, and n is the order of the reaction. 
The calculated values are presented in Table I. The calculated values of every regression 
line slopes were very close to 1.0 (1.033, 1.077 and 1.076 for PEN, MPG and GSH determina-
tion, resp.), confirming that the proposed reactions of all these analytes are first-order in 
respect to analytes concentrations.
Fixed time method. – The absorbance of the solution containing different RSH concen-
trations were recorded at a fixed time. Throughout the optimization part of the fixed time 
method, various time intervals (30, 60, 120 and 180 s) were observed for the absorbance 
recording. Calibration plots were created for the tested time periods, for each analyte. 
Regarding to sensitivity and concentration range, no significant differences were observed 
for the tested time periods, Therefore, the fixed time of 60 s after addition of analyte was 
Table I. Analytical parameters for the kinetic determination of RSH using the initial rate method
Analyte Linear range (mol L–1)
log K = n log c + log k’
R2 LOD (mol L–1)
Slope (n) a Intercept (log k’) a
PEN 8.0 × 10‒7 – 8.0 × 10‒5 1.033 ± 0.011 3.080 ± 0.035 0.9981 2.4 × 10‒7
MPG 8.0 × 10‒7 – 8.0 × 10‒5 1.077 ± 0.013 3.300 ± 0.038 0.9996 2.4 × 10‒7
GSH 6.0 × 10‒7 – 8.0 × 10‒5 1.076 ± 0.014 3.322 ± 0.040 0.9976 1.8 × 10‒7
Experimental conditions: c(Cu2+) = 1.0 × 10−4 mol L−1; c(Nc) = 2.4 × 10−4 mol L−1; pH = 3.0; temperature 25 °C.
a Average of three determinations ± SD.
Table II. Analytical parameters for the kinetic determination of RSH using the fixed time method
Analyte Linear range (mol L–1)
y = ax + b
R2 LOD (mol L–1)
Slope (a) a Intercept (b) a
PEN 6.0 × 10‒7 – 8.0 × 10‒5 7186 ± 79 0.0009 ± 1×10‒5 0.9997 1.4 × 10‒7
MPG 6.0 × 10‒7 – 6.0 × 10‒5 7470 ± 95 –0.0006 ± 9×10‒6 0.9999 1.4 × 10‒7
GSH 6.0 × 10‒7 – 6.0 × 10‒5 7426 ± 89 –0.0034 ± 4×10‒5 0.9999 1.1 × 10‒7
Experimental conditions: c(Cu2+) = 1.0 × 10−4 mol L−1; c(Nc) = 2.4 × 10−4 mol L−1; pH = 3.0; temperature 25 °C.
Sampling time was 60 s after adding the analyte and signal sampling, and 120 s after the beginning of the measurement.
a Average of three determinations ± SD.
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selected for all of the proposed methods. The determination coefficients, regression 
 equations, linear range and LOD for each analyte in pre-selected fixed time (120 s of the 
 measurement) are given in Table II.
Analytical performances
Accuracy and precision. – The results showed that the recovery of the developed  kinetic 
methods processed by both calculational methods were in the range from 98.6 to 102.8 % 
with RSD < 2 % (Table III). The results supported the accuracy and precision of developed 
kinetic methods as well as the absence of interference from the excipients in the used 
samples.
Selectivity. – With regard to the calculated tolerance limit, even 500 times higher 
amount (2.0 × 10–2 mol L–1) of the tested ionic species (Na+, K+, NO3–, SO42–) and organic 
acids (boric, tartaric and citric acid) did not cause interference with the absorbance signal. 
Furthermore, 100 times higher concentration of sugar (glucose, fructose, sucrose and lac-
tose) did not interfere as well.
Table III. Testing the accuracy of the new methods for the determination of RSH
Sample













Metalcaptaseb 0.0 100.7 ± 0.3 – 0.0 99.8 ± 0.4 –
50.0 151.4 ± 1.0 101.4 50.0 150.9 ± 0.9 102.2
100.0 202.6 ± 1.2 101.9 100.0 201.7 ± 1.3 101.9
150.0 252.7 ± 1.9 101.3 150.0 252.6 ± 2.0 101.9
200.0 303.8 ± 2.1 101.6 200.0 302.8 ± 2.4 101.5
Captimerc 0.0 101.0 ± 0.6 – 0.0 100.3 ± 0.3 –
50.0 151.4 ± 1.3 100.8 50.0 149.6 ± 0.9 98.6
100.0 202.6 ± 1.9 101.6 100.0 199.5 ± 1.4 99.2
150.0 253.5 ± 2.0 101.7 150.0 254.7 ± 2.3 102.9
200.0 304.7 ± 2.2 101.9 200.0 305.8 ± 2.6 102.8
L-glutathioned 0.0 100.6 ± 0.2 – 0.0 100.8 ± 0.3 –
50.0 151.3 ± 0.9 101.4 50.0 152.0 ± 1.1 102.4
100.0 201.7 ± 1.6 101.1 100.0 202.3 ± 1.3 101.5
150.0 254.2 ± 1.9 102.4 150.0 254.1 ± 2.0 102.2
200.0 304.4 ± 2.1 101.9 200.0 305.0 ± 2.3 102.1
a Average of three determinations ± SD.
b Tablets containing PEN 300 mg.
c Tablets containing MPG 100 mg.
d Capsules containing GSH 50 mg.
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It should be noted that the occurrence of interference is expected in the presence of 
substances that are strong reducing agents, such as ascorbic acid and other RSHs. How-
ever, such reducing agents are not normally included in pharmaceutical formulations 
containing PEN, MPG and GSH. The reported standard potential of CuII/CuI couple in the 
solution of neocuproine (0.603 V) (44) specify that only the reducing substances with 
standard (formal) potential lower than 0.6 V would have the thermodynamic predisposi-
tion to interfere with the proposed methods.
Method application
To test the potential of the new methods for the analysis of real samples, both  methods 
were applied to the determination of RSH in commercially available pharmaceutical 
formulations. Official methods from the British Pharmacopoeia were used for compa-
rison (8). As MPG is an orphan drug and there is no specific assay for MPG described in 
the British Pharmacopoeia, we used the method described for measurement of acetyl-
cysteine, a thiol compound with the same molecular mass as MPG, for comparison of the 
methods. There were no statistically significant differences between the values obtained 
by the official methods and those obtained by the two new approaches (Table IV). This 
indicates that the new method is not inferior to the official method, in terms of accuracy 
and precision.
Performance characteristics of the published kinetic spectrophotometric methods 
for the determination of PEN (36–40) and MPG (41) in pharmaceuticals, and the novel 
methods, are compared in Table V. As we have previously remarked, we could not find 
in the literature any kinetic spectrophotometric methods for determination of GSH in 
pharmaceuticals. Therefore, the presented method would be the first published kinetic 
spectrophotometric method for the determination of glutathione in pharmaceuticals. 
The new methods (initial rate and fixed time) have quite a few advantages over previ-
ously reported methods: wide linear dynamic concentration range (two decades), higher 
sensitivity, speed (1 min for fixed time method) and measurement performed in the  visible 
region (λ = 458 nm) – away from the UV-absorbance of the UV-absorbing interfering 
 excipient materials.














Metalcaptaseb 301.9 ± 2.5 0.1846 1.254 302.2 ± 2.6 0.3173 1.160 301.5 ± 2.8c
Captimerd 101.5 ± 1.2 0.3757 1.361 100.9 ± 1.1 0.1946 1.620 101.1 ± 1.4e
L-glutathionef 51.1 ± 0.8 1.1410 1.306 50.7 ± 0.9 1.6710 1.653 51.8 ± 0.7g
a Average of three determinations ± SD.
b Calculated per tablet containing PEN 300 mg. c Acid-base titration in non-aqueous medium.
d Calculated per tablet containing MPG 100 mg. e Redox titration.
f Calculated per capsule containing GSH 50 mg. g Redox titration.
h Tabulated values, p = 0.05: t(4) = 2.776, F(2,2) = 19.0 (degrees of freedom in parentheses).
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CONCLUSIONS
The present study demonstrates the potential application of simple kinetic spectro-
photometric methods for assaying of penicillamine, tiopronin and glutathione in pharma-
ceutical formulations. The new method is based on a redox reaction where the RSH  reduces 
CuII-neocuproine complex to CuI-neocuproine complex. It is adequately sensitive and 
 accurate to be used for routine quantification of RSH without expensive reagents and 
 instruments. The advantages of the proposed method over the previously published 
 kinetic spectrophotometric methods include a wide linearity range, higher sensitivity and 
speed.
Supplementary material available upon request.
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